Heart Of Hospice Medicare Approved Location: 233 Pecan Park Avenue Suite C And D, Alexandria, Louisiana 71303 Phone: (318) 880-0223 |
Christus Hospice & Palliative Care St Frances Cabr Medicare Approved Location: 4801 Jackson Street Ext Suite B, Alexandria, Louisiana 71303 Phone: (318) 448-6764 |
St Joseph Hospice Of Cenla, Llc Medicare Approved Location: 716 Versailles Blvd, Alexandria, Louisiana 71303 Phone: (318) 561-0100 |
Faith Foundation Hospice, Inc Medicare Approved Location: 3503 Parliament Court, Alexandria, Louisiana 71303 Phone: (318) 443-5545 |
Gamble Hospice Care Medicare Approved Location: 3805 Halsey Street, Suite C, Alexandria, Louisiana 71303 Phone: (318) 619-9457 |
Still Waters Hospice, Llc Medicare Approved Location: 3033 Jackson Street, Alexandria, Louisiana 71301 Phone: (318) 767-2000 |
Guardian Hospice Care,llc Medicare Approved Location: 5212 Rue Verdun, Alexandria, Louisiana 71303 Phone: (318) 484-4418 |
Compasionate Care Hospice Medicare Approved Location: 5417 Jackson Street, Suite B, Alexandria, Louisiana 71303 Phone: (318) 487-9400 |
Harbor Hospice Of Alexandria, Lp Medicare Approved Location: 2006 Gus Kaplan Drive, Alexandria, Louisiana 71301 Phone: (318) 442-1491 |
News Archive
A study led by investigators at Massachusetts General Hospital and University Health Network in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis - scarring and excessive tissue deposition that result from abnormal healing responses and can compromise the function of vital organs.
Recent news coverage has consumers concerned about the alarming amount of contaminants, such as pesticides and heavy metals, being found in herbal supplements. NSF International, an independent, not-for-profit public health organization, helps ease these concerns by testing and certifying supplements to ensure they are free of undeclared substances and unacceptable contaminants.
MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%.
York University Professor Joel Katz is studying methods of preventing or significantly reducing pain after surgery by employing preemptive or preventive analgesia to treat pain before it develops.
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, suggests that the widely used osteoporosis drug alendronate reduces the risk of type 2 diabetes.
› Verified 3 days ago